Skip to main content

Table 3 Cost-effectiveness of rotavirus vaccine, (lower limit, upper limit)

From: Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study

Incremental cost-effectiveness ratio (US$) RI value SIA value
Cost per DALY averted 5.30 (1.35-14.28) 37.62 (12.86-74.93)
Cost per case averted 2.81 (0.58-6.15) 16.20 (5.54-21.54)
Cost per death averted 270.56 (68.85-729.62) 1,921.52 (656.90-2,553.83)